CL
HRMY icon

CIM LLC’s Harmony Biosciences HRMY Stock Holding History

CIM LLC’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$366K Hold
13,080
– – 0.05% 139
2025
Q4 		$489K Sell
13,080
-561
-4% -$18.4K 0.06% 124
2025
Q3 		$376K Hold
13,641
– – 0.05% 137
2025
Q2 		$431K Buy
13,641
+730
+6% +$23.5K 0.06% 126
2025
Q1 		$429K Sell
12,911
-485
-4% -$17.4K 0.06% 113
2024
Q4 		$461K Buy
13,396
+92
+0.7% +$3.16K 0.07% 123
2024
Q3 		$532K Sell
13,304
-217
-2% -$7.62K 0.08% 113
2024
Q2 		$481K Buy
13,521
+1,705
+14% +$51.3K 0.07% 109
2024
Q1 		$397K Buy
11,816
+117
+1% +$3.75K 0.06% 117
2023
Q4 		$368K Buy
11,699
+3,257
+39% +$90.9K 0.06% 116
2023
Q3 		$277K Buy
8,442
+835
+11% +$29K 0.05% 125
2023
Q2 		$268K Buy
7,607
+418
+6% +$14.4K 0.05% 131
2023
Q1 		$235K Sell
7,189
-183
-2% -$8.33K 0.05% 138
2022
Q4 		$353K Sell
7,372
-277
-4% -$15.2K 0.07% 123
2022
Q3 		$453K Buy
7,649
+533
+7% +$26K 0.1% 107
2022
Q2 		$390K Sell
7,116
-106
-1% -$4.77K 0.08% 105
2022
Q1 		$341K Buy
+7,222
New +$295K 0.06% 116

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CIM LLC's HRMY Position: Q1 2026 in Review

CIM LLC held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 13,080 shares worth $366K. The position accounts for 0.05% of the portfolio, ranked #139.

CIM LLC first reported a position in HRMY in Q1 2022 and has held it in 17 quarters since. The position peaked at $532K in Q3 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • CIM LLC held 13,080 shares of Harmony Biosciences worth $366K as of Q1 2026.
  • CIM LLC left its Harmony Biosciences share count unchanged in Q1 2026.
  • Harmony Biosciences made up 0.05% of CIM LLC's portfolio in Q1 2026, its #139 holding.
  • CIM LLC first reported a position in Harmony Biosciences in Q1 2022 and has held it in 17 quarters since.
  • CIM LLC's Harmony Biosciences position peaked at $532K in Q3 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on CIM LLC's 13F filing for Q1 2026, filed 18 May 2026.